Myovant Sciences - Stock Split History | MYOV
Stock split history for Myovant Sciences since 2022. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|Myovant Sciences Annual Stock Splits
|Myovant Sciences Quarterly Stock Splits
||Medical - Biomedical and Genetics
Myovant Sciences Ltd. is a biopharmaceutical company. It focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders, including advanced prostate cancer. The company's product candidate consists of relugolix which are in clinical trial, an oral once-daily small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. Myovant Sciences Ltd. is based in Hamilton, Bermuda.